| 1 | Clinical guidelines «Rational use of nonsteroidal anti-infla… (10.14412/1996-7012-2015-1-4-23) | Abstract References ORCID License | 177.82 | 59 |
| 2 | Psoriatic arthritis. Clinical guidelines for diagnosis and t… (10.14412/1996-7012-2018-2-22-35) | Abstract References ORCID License | 143.14 | 26 |
| 3 | Aceclofenac: the experience of Russian studies (10.14412/1996-7012-2017-4-89-94) | Abstract References ORCID License | 130.10 | 19 |
| 4 | Indicators of the osteoclastogenesis system in men with diff… (10.14412/1996-7012-2015-2-23-27) | Abstract References ORCID License | 117.61 | 14 |
| 5 | Chronic kidney disease: the role of hyperuricemia and the po… (10.14412/1996-7012-2018-1-60-65) | Abstract References ORCID License | 117.61 | 14 |
| 6 | Differential chemoreactome analysis of glucosamine sulfate a… (10.14412/1996-7012-2018-2-36-43) | Abstract References ORCID License | 117.61 | 14 |
| 7 | Minor rheumatology: Nonsystemic rheumatic disease of juxta-a… (10.14412/1996-7012-2015-2-4-15) | Abstract References ORCID License | 114.61 | 13 |
| 8 | Knee osteoarthrosis: Clinical presentation, diagnosis, treat… (10.14412/1996-7012-2013-277) | Abstract References ORCID License | 107.92 | 11 |
| 9 | EICOSANOIDS AND INFLAMMATION (10.14412/1996-7012-2016-4-73-86) | Abstract References ORCID License | 107.92 | 11 |
| 10 | Destabilized hypertension as a complication of therapy with… (10.14412/1996-7012-2018-2-64-72) | Abstract References ORCID License | 107.92 | 11 |
| 11 | Progress in rheumatology in the early 21st century (10.14412/1996-7012-2014-3-4-8) | Abstract References ORCID License | 104.14 | 10 |
| 12 | Comparative study of the efficacy and safety of Chondroguard… (10.14412/1996-7012-2018-2-44-49) | Abstract References ORCID License | 104.14 | 10 |
| 13 | Clinical rationale for the use of various teraflex formulati… (10.14412/1996-7012-2010-639) | Abstract References ORCID License | 100.00 | 9 |
| 14 | Osteonecrosis. Part 1. Risk factors and pathogenesis (10.14412/1996-7012-2013-2362) | Abstract References ORCID License | 100.00 | 9 |
| 15 | Familial Mediterranean fever (a periodic disease): The prese… (10.14412/1996-7012-2013-2363) | Abstract References ORCID License | 100.00 | 9 |
| 16 | Russian experience with injectable chondroitin sulfate and g… (10.14412/1996-7012-2018-1-33-40) | Abstract References ORCID License | 100.00 | 9 |
| 17 | Role of interleukin-6 in the development of atherosclerosis… (10.14412/1996-7012-2013-7) | Abstract References ORCID License | 95.42 | 8 |
| 18 | Autoinflammatory diseases: An immunologist’s view (10.14412/1996-7012-2015-1-48-54) | Abstract References ORCID License | 95.42 | 8 |
| 19 | Current approaches to diagnosing and treating macrophage act… (10.14412/1996-7012-2015-1-55-59) | Abstract References ORCID License | 95.42 | 8 |
| 20 | DETECTION RATES OF PSORIATIC ARTHRITIS IN PATIENTS WITH PSOR… (10.14412/1996-7012-2016-4-47-50) | Abstract References ORCID License | 95.42 | 8 |
| 21 | Osteoarthrosis in outpatient practice (10.14412/1996-7012-2012-766) | Abstract References ORCID License | 90.31 | 7 |
| 22 | Sociomedical sequels and quality of life in patients of old… (10.14412/1996-7012-2014-3-51-55) | Abstract References ORCID License | 90.31 | 7 |
| 23 | Clinical experience with the interleukin-1β blocker canakinu… (10.14412/1996-7012-2015-2-16-22) | Abstract References ORCID License | 90.31 | 7 |
| 24 | REBAMIPIDE: EFFECTIVE DRUG PREVENTION OF NSAID ENTEROPATHY I… (10.14412/1996-7012-2016-4-97-105) | Abstract References ORCID License | 90.31 | 7 |
| 25 | Osteoarthritis: aspects of pharmacotherapy (10.14412/1996-7012-2018-2-97-102) | Abstract References ORCID License | 90.31 | 7 |
| 26 | Progressive multifocal leukoencephalopathy: rheumatological… (10.14412/1996-7012-2015-3-4-9) | Abstract References ORCID License | 84.51 | 6 |
| 27 | The place of intravenous immunoglobulin in rheumatic disease… (10.14412/1996-7012-2015-4-59-67) | Abstract References ORCID License | 84.51 | 6 |
| 28 | Current approaches to diagnosis, treatment, and monitoring i… (10.14412/1996-7012-2016-2-4-11) | Abstract References ORCID License | 84.51 | 6 |
| 29 | Rheumatic manifestations of hypothyroidism (10.14412/1996-7012-2017-2-47-53) | Abstract References ORCID License | 84.51 | 6 |
| 30 | Comparative efficacy and safety of infliximab biosimilar (BC… (10.14412/1996-7012-2017-3-14-25) | Abstract References ORCID License | 84.51 | 6 |
| 31 | SYMPTOMATIC THERAPY FOR PAIN IN RHEUMATIC DISEASES: A PLACE… (10.14412/1996-7012-2009-560) | Abstract References ORCID License | 77.82 | 5 |
| 32 | PYROPHOSPHATE ARTHROPATHY IS A RHEUMATOLOGICAL ICEBERG SYNDR… (10.14412/1996-7012-2010-595) | Abstract References ORCID License | 77.82 | 5 |
| 33 | X-RAY DIAGNOSIS OF PRIMARY OSTEOPOROSIS (10.14412/1996-7012-2011-651) | Abstract References ORCID License | 77.82 | 5 |
| 34 | Role of immune inflammation in the pathogenesis of osteoarth… (10.14412/1996-7012-2011-705) | Abstract References ORCID License | 77.82 | 5 |
| 35 | Osteoarthrosis: An old disease, novel approaches (10.14412/1996-7012-2013-2388) | Abstract References ORCID License | 77.82 | 5 |
| 36 | Aceclofenac in rheumatology: The golden mean (10.14412/1996-7012-2013-2389) | Abstract References ORCID License | 77.82 | 5 |
| 37 | All-russian registry of rheumatoid arthritis patients: prese… (10.14412/1996-7012-2014-1-84-86) | Abstract References ORCID License | 77.82 | 5 |
| 38 | On the way toward designing next-generation nonsteroidal ant… (10.14412/1996-7012-2014-2-83-89) | Abstract References ORCID License | 77.82 | 5 |
| 39 | Diabetes mellitus and hyperglycemia in patients with rheumat… (10.14412/1996-7012-2014-3-23-27) | Abstract References ORCID License | 77.82 | 5 |
| 40 | Place of hyaluronic acid preparations in therapy for osteoar… (10.14412/1996-7012-2014-3-73-76) | Abstract References ORCID License | 77.82 | 5 |
| 41 | Intra-articular drug injections in the combination treatment… (10.14412/1996-7012-2015-1-78-83) | Abstract References ORCID License | 77.82 | 5 |
| 42 | Analgesic treatment, by using a systemic algorithm (10.14412/1996-7012-2015-2-37-50) | Abstract References ORCID License | 77.82 | 5 |
| 43 | Systemic lupus erythematosus: Specific features of its cours… (10.14412/1996-7012-2015-3-43-47) | Abstract References ORCID License | 77.82 | 5 |
| 44 | The 2015 guidelines for the laboratory diagnosis of rheumati… (10.14412/1996-7012-2015-4-25-36) | Abstract References ORCID License | 77.82 | 5 |
| 45 | The 2014 guidelines for the management of osteoarthritis: Pl… (10.14412/1996-7012-2015-4-37-43) | Abstract References ORCID License | 77.82 | 5 |
| 46 | Neonatal lupus (10.14412/1996-7012-2015-4-92-97) | Abstract References ORCID License | 77.82 | 5 |
| 47 | Naproxen: A universal analgesic with a minimal risk of cardi… (10.14412/1996-7012-2016-2-70-77) | Abstract References ORCID License | 77.82 | 5 |
| 48 | Injury to the joint and spinal column in patients with infla… (10.14412/1996-7012-2016-2-78-82) | Abstract References ORCID License | 77.82 | 5 |
| 49 | Osteoarthritis: Key elements in its pathogenesis and current… (10.14412/1996-7012-2017-3-121-128) | Abstract References ORCID License | 77.82 | 5 |
| 50 | The daily arterial stiffness profile in rheumatoid arthritis… (10.14412/1996-7012-2017-3-64-71) | Abstract References ORCID License | 77.82 | 5 |